Method development, validation and comparative study of generic Vs. branded generic formulations of amoxicillin trihydrate in capsule dosage form by Gandhi, Santosh V. & Mahajan, Mohitosh R.
Gandhi et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):186-192 
ISSN: 2250-1177                                                                                  [186]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.06.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Method development, validation and comparative study of generic Vs. 
branded generic formulations of amoxicillin trihydrate in capsule dosage 
form 
Gandhi Santosh V. *, Mahajan Mohitosh R.  
Department of Pharmaceutical Quality Assurance, All India Shri Shivaji Memorial Society’s College of Pharmacy, Kennedy Road, Near R.T.O., 
Pune, Maharashtra, India-411001 
 
ABSTRACT 
The present work relates to development and validation of simple, precise and sensitive UV spectrometric and high-performance thin layer 
chromatographic (HPTLC) method for the analysis of Amoxicillin Trihydrate in Capsule dosage form. Method were developed and applied for 
comparative study of generic vs branded generic formulations of Amoxicillin Trihydrate.  Amoxicillin Trihydrate in methanol shows maximum 
absorbance at 229 nm and the data of linear regression analysis indicated a good linear relationship over the concentration range of 5-30 µg/ml 
with a correlation coefficient (R2) 0.998 by UV- Spectroscopy and the concentration range of 2000-12000 ng/band with a correlation coefficient 
(R2) 0.997 by HPTLC. The main objective was to compare and evaluate the price and quality of branded generic and generic formulations of 
Amoxicillin Trihydrate 250 mg Capsule. The evaluation parameters like content of active ingredients, content uniformity test, mass variation, 
disintegration test, and in vitro release studies were performed as described in Indian Pharmacopeia 2010.  
Keywords: Branded Generic, Generic, Quantitative and Qualitative Determination, Ultraviolet Spectroscopy, HPTLC, Comparative Studies.   
 
Article Info: Received 23 April 2019;     Review Completed 25 May 2019;     Accepted 29 May 2019;     Available online 15 June 2019 
Cite this article as: 
Gandhi SV, Mahajan MR, Method development, validation and comparative study of generic Vs. branded generic 
formulations of amoxicillin trihydrate in capsule dosage form, Journal of Drug Delivery and Therapeutics. 2019; 9(3-
s):186-192   http://dx.doi.org/10.22270/jddt.v9i3-s.2821                                                          
*Address for Correspondence:  
Dr. Santosh V. Gandhi, Professor, AISSMS College of Pharmacy, Kennedy Road, Near R.T.O, Pune -411001, Maharashtra, India. 
 
INTRODUCTION 
Analytical chemistry spreads its application in many allied 
areas. Especially in the pharmaceutical industry; quality of 
the manufactured drugs in tablets, solutions, suspension or 
other dosage form must be carefully controlled. Slight 
variation in composition or in the purity of drug itself can 
affect therapeutic value. Therefore, there is constant need to 
develop newer and better methods for pharmaceutical 
analysis. The main objective of this study is to carry 
comparative study and evaluate the price and quality for 
certain drugs for their IPQC tests and dissolution studies in 
Branded Vs Generic solid dosage forms. As there is belief 
that due to its cheaper cost and non-popularity generic 
medicines are of poor quality. The marketing cost is also 
saved, government takes responsibility to decide the price of 
medicines and due to competition between manufacturers 
the cost of generic medicines is less compare to branded 
ones. In case of branded medicines, the time and its 
development cost need to be paid more for the original 
company that’s why the branded medicines are costlier than 
the generic medicines [1,2]. The generic and branded generic 
formulation of the drug should have same strength, quality 
and physicochemical properties [3].  We need to ensure that 
both formulations are pharmaceutically and therapeutically 
same.  
Amoxicillin is [[2S [2α,5α,6β, (S*)]]-6-[[Amino(4-
hydroxyphenyl) acetyl] amino]-3, 3-dimethyl-7-oxo-4-thia-
1-azabicyclo [3.2.0] heptane-2-carboxilic acid]. )1) is an oral 
semi-synthetic penicillin structurally related to ampicillin. 
Amoxicillin is β -lactam antibiotic that belong to the group of 
penicillin. It is semi-synthetic, broad spectrum, acid stable, 
orally absorbed antibiotics that inhibit bacterial cell, it is 
normally used for the treatment of common bacterial 
infection [4]. 
  
Fig I: Chemical structure of Amoxicillin Trihydrate 
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Various methods were observed during literature survey for 
the quantitative determination of Amoxicillin Trihydrate, 
which includes UV [5-9], HPLC [10,11], HPTLC [12-14]. 
As per the literature survey the data represents that there is 
no reported comparative study for the estimation of 
Amoxicillin Trihydrate in pharmaceutical Capsule dosage, 
hence based on these observations we have developed a 
comparative study on generic and branded generic 
formulations  for the determination of Amoxicillin 
Trihydrate in bulk and Capsule dosage form in accordance 
with International Conference on Harmonization 
Guidelines[15]. 
MATERIALS AND METHODS 
Reagents and chemicals 
Amoxicillin Trihydrate Capsules I.P labeled to contain 
Amoxicillin Trihydrate 250 mg was purchased from local 
market. Methanol (AR grade), Methanol (HPTLC grade), 
Acetic acid (AR grade), Ethyl acetate (AR grade), were used 
in study. 
Preparation of standard stock solution:  
Standard stock solution of drug Amoxicillin Trihydrate was 
prepared by dissolving 10 mg of drug in 10 ml of methanol 
to get concentration of 1000 µg/ml. From this standard 
solution 1 ml was taken in 10 ml volumetric flask and 
volume was made up with methanol to get solution of 
concentration 100 µg/ml. Further 1 ml of this solution was 
diluted to 10 ml with methanol to get resulting solution of 
concentration 10 µg/ml. 
Selection of detection wavelength: 
From the standard stock solution (1000 μg/ml) further 
dilutions were made using methanol and scanned over the 
range of 200-400 nm and the spectra were obtained. It was 
observed that the drug showed linear, stable and 
considerable absorbance at 229 nm. Representative UV 
spectrum was obtained shown in Figure 1. 
 
 
Figure 1:  UV Spectrum of Amoxicillin Trihydrate (10 µg/ml) 
Chromatographic conditions: 
Chromatographic conditions were optimised by using CAMAG HPTLC system equipped with Camag Linomat V sample 
applicator, Hamilton syringe (100 µL), Camag TLC Scanner-3 with winCATS software version 1.4.2 and Camag twin- trough 
chamber (10×10 cm) were used for the present study.  Chromatographic separation was established by using precoated Silica 
gel 60 F254 TLC plates (10×10 cm, layer thickness 0.2 mm, E. Merck, Germany) as stationary phase and Ethyl Acetate: Acetic 
acid: Water (6: 2: 2, v/v/v) as mobile phase. Detection wavelength of 229 nm was employed during scanning and the band 
width 6 mm was fixed during spotting. Representative HPTLC chromatograph is given in Fig. 2. 
 
Figure 2:  HPTLC Densitogram of Amoxicillin Trihydrate (2000 ng/band) 
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Preparation of sample solution: 
Contents from the twenty capsules of Amoxicillin trihydrate 
were removed. The quantity of capsule powder equivalent to 
10 mg of Amoxicillin Trihydrate (label claim: 250 mg 
Amoxicillin Trihydrate per Capsule) was transferred to a 10 
ml volumetric flask containing 5 ml of methanol. The mixture 
was subjected for ultra-sonication for the period of 10 min 
and the resulting sample stock solution was filtered with 
Whatman filter paper 41 and the volume was made up with 
the methanol. 1.0 ml of this solution was diluted to 10 ml 
with the methanol to prepare a final sample stock solution of 
100 μg/ml. 
RESULTS AND DISCUSSION 
Validation of analytical method [15] 
Linearity and Range: 
From standard stock solution (1000 μg/ml) of Amoxicillin 
Trihydrate, solution was prepared containing 100 μg/ml of 
Amoxicillin Trihydrate in methanol. Further 1ml was taken 
and diluted to 10ml with methanol in volumetric flask to get 
100 μg/ml.  This solution was further diluted with methanol 
to get range of solution containing different concentrations 
5-30 μg/ml for the Ultraviolet spectroscopy. Absorbance was 
recorded. From standard stock solution (1000 μg/ml) of 
Amoxicillin Trihydrate spotting was done in the 
concentration range of 2000 – 12000 ng/band for the 
HPTLC. Area was recorded. The equation of calibration curve 
by UV- Spectroscopy and HPTLC was found to be y = 0.0195x 
+ 0.0318 and y = 0.9995x + 480.77 respectively. The 
absorbance/area of drug was plotted against the 
corresponding concentrations to obtain the calibration curve 
as shown in Figure 3 and Figure 4 respectively. 
 
 
Figure 3: Linearity curve of Amoxicillin Trihydrate by UV- Spectroscopy (5-30 µg/ml). 
 
Figure 4: Linearity curve of Amoxicillin Trihydrate by HPTLC (200-1200 ng/band). 
 
Precision: 
The precision of the method was demonstrated by intra-day 
and inter-day variation studies. In the Intra-day studies, 3 
replicates of 3 different concentrations were analyzed in a 
day and percentage RSD was calculated. For the inter-day 
variation studies, 3 different concentrations were analyzed 
on 3 consecutive days and percentage RSD was calculated. 
The results obtained for intra-day and inter-day variations 
by UV-Spectroscopy and HPTLC are shown in Table 1 and 
Table 2 respectively. 
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Table 1: Intra-day and Inter-day variation studies data for Amoxicillin Trihydrate by UV-Spectroscopy. 
Replicates 
Intra-day Precision Inter-day Precision 
Conc. (µg/ml) Conc. (µg/ml) 
10 15 25 10 15 25 
Abs Abs Abs Abs Abs Abs 
1 0.2307 0.3294 0.5171 0.2297 0.3289 0.529 
2 0.2258 0.3289 0.5263 0.2258 0.3287 0.5203 
3 0.2294 0.3252 0.5201 0.2304 0.3302 0.5161 
Mean 0.2286 0.3278 0.5212 0.2286 0.3293 0.5218 
SD 1.302 0.784 0.962 1.271 0.278 1.350 
%RSD 1.29 0.77 0.96 1.26 0.27 1.34 
 
Table 2: Intra-day and Inter-day variation studies data for Amoxicillin Trihydrate by HPTLC. 
Replicates 
Intra-day Precision Inter-day Precision 
Conc. (µg/ml) Conc. (µg/ml) 
10 15 25 10 15 25 
Area Area Area Area Area Area 
1 4487.3 6407.6 10581.8 4424.4 6507.1 10381.9 
2 4474.5 6481.7 10636.3 4527 6581.3 10436.4 
3 4569.6 6504.3 10518.7 4425.3 6404.4 10418.5 
Mean 4510.5 6464.5 10578.9 4458.9 6497.6 10412.3 
SD 1.291 0.843 0.589 1.475 1.481 0.278 
%RSD 1.28 0.85 0.58 1.48 1.48 0.28 
 
Limit of detection (LOD) and limit of quantitation (LOQ): 
From the linearity data the LOD and LOQ was calculated, 
using the formula LOD = 3.3 σ/S and LOQ = 10 σ/S, where σ 
= standard deviation of the y intercept of linearity equations 
and S = slope of the calibration curve of the analyte. The LOD 
and LOQ by UV-Spectroscopy were found to be 0.455 μg/ml 
and 1.378 μg/ml, respectively and The LOD and LOQ by 
HPTLC were found to be 36.24 μg/ml and 109.82 μg/ml, 
respectively. 
Accuracy:  
To check accuracy of the method, recovery studies were 
carried by spiking the standard 250 mg Capsule sample 
solution, at three different levels around 50, 100 and 150%. 
Basic concentration of sample solution chosen was 10 µg/ml 
for UV and 4000 ng/band for HPTLC of Amoxicillin 
Trihydrate. % recovery was determined from linearity 
equation. The results obtained are shown in Table 3 and 
Table 4. 
 
Table 3: Accuracy of Amoxicillin Trihydrate by UV-Spectroscopy. 
Level 
Conc. of 
Sample 
solution 
(µg/ml) 
Conc. of 
Standard 
solution 
spiked 
(µg/ml) 
Wymox Aequimox 
Absorbance 
Amount 
recovered 
(µg/ml) 
 
% 
recovery 
 
 
Absorbance 
Amount 
recovered 
(µg/ml) 
 
% 
recovery 
 
 
 
50% 
 
10 5 
0.3191 14.733 
98.92 
0.3209 14.826  
100.536 0.322 14.882 0.3331 15.451 
0.3224 14.903 0.3236 14.964 
 
100% 
 
 
10 
 
 
10 
 
0.4306 20.451 
102.69 
0.4331 20.579  
 
102.803 
0.4317 20.508 0.4362 20.738 
0.4346 20.656 0.4289 20.364 
 
150% 
 
 
10 
 
 
15 
 
0.5293 25.513 
100.47 
0.5273 25.410  
 
101.682 
0.5187 24.969 0.5287 25.482 
0.5169 24.877 0.5265 25.369 
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Table 4: Accuracy of Amoxicillin Trihydrate by HPTLC. 
Level 
Conc. of 
Sample 
solution 
(µg/ml) 
Conc. of Standard 
solution spiked 
(µg/ml) 
Wymox Aequimox 
Area 
Amount 
recovered 
(µg/ml) 
 
% 
recovery 
 
 
Area 
Amount 
recovered 
(µg/ml) 
 
% 
recovery 
 
 
 
50% 
 
 
10 5 
6507.1 6029.34 
100.331 
 
6407.6 5929.79  
99.78 
 
6581.3 6103.58 6481.7 6003.93 
6404.4 5926.59 6504.3 6026.54 
 
100% 
 
 
 
10 
 
 
 
10 
 
 
8345.3 7868.46 
99.005 
 
8445.4 7968.61  
99.43 
 
8398.3 7921.49 8498.8 8022.04 
8448.1 7971.32 8348.5 7871.67 
 
150% 
 
 
 
10 
 
 
 
15 
 
 
10581.
9 10106.18 
101.365 
 
10781.8 10306.18 
 
101.03 
 10636.
4 10160.71 10536.3 10060.56 
10618.
3 10142.60 10418.7 9942.90 
 
Assay: 
Amoxicillin Trihydrate Capsules I.P labeled to contain 
Amoxicillin Trihydrate 250 mg formulation analysis was 
carried out as mentioned under section preparation of 
sample solution and absorbance/area was recorded. Basic 
concentration of sample chosen was 10 μg/ml for UV and 
4000 ng/band for HPTLC from Capsule solution. Procedure 
was repeated for six times. Concentration and % recovery 
was determined from linear equation. The results obtained 
by UV-Spectroscopy and HPTLC are shown in Table 5 and 
Table 6 respectively. 
 
Table 5: Assay of marketed formulation by UV-Spectroscopy. 
 
Sr. 
No. 
Wymox Aequimox 
Absorbance 
Amount Recovered 
(µg/ml) 
% 
Recovery 
Absorbance 
Amount Recovered 
(µg/ml) 
% 
Recovery 
1 0.2256 9.94 99.38 0.2298 10.154 101.538 
2 0.2299 10.16 101.59 0.2306 10.195 101.949 
3 0.2238 9.85 98.46 0.2292 10.123 101.231 
4 0.2284 10.08 100.82 0.2214 9.723 97.231 
5 0.2323 10.28 102.82 0.2244 9.877 98.769 
6 0.2306 10.19 101.95 0.2249 9.903 99.026 
Mean 0.228 10.084 100.838 0.227 9.996 99.957 
SD 0.003 0.164 1.643 0.004 0.189 1.887 
%RSD 1.402 1.629 1.629 1.623 1.888 1.888 
  
Table 6: Assay of marketed formulation by HPTLC 
 
Sr. No. 
Wymox Aequimox 
Area 
Amount Recovered 
(µg/ml) 
% 
Recovery 
Area 
Amount Recovered 
(µg/ml) 
% 
Recovery 
1 4564.5 4085.77 102.14 4464.4 3985.62 99.64 
2 4497 4018.24 100.46 4597 4118.29 102.96 
3 4525.2 4046.45 101.16 4425.3 3946.50 98.66 
4 4487.3 4008.53 100.21 4587.8 4109.08 102.73 
5 4474.5 3995.73 99.89 4576.6 4097.88 102.45 
6 4569.6 4090.88 102.27 4469.7 3990.93 99.77 
Mean 4519.683 4040.934 101.023 4520.133 4041.384 101.035 
SD 40.337 40.357 1.009 75.258 75.296 1.882 
%RSD 0.892 0.999 0.999 1.665 1.863 1.863 
 
In-vitro dissolution studies:[16] 
The in-vitro dissolution study was carried out by using IP 
Type-2 dissolution apparatus at 100 rpm. For the dissolution 
study randomly 6 Capsules of both branded generic and 
generic formulations are selected. Media used was RO 
purified water. Sufficient volume was removed, filtered by 
Whatman filter paper and diluted up to 10 ml in 10 ml 
volumetric flask and scanned over the UV-Spectroscopy. The 
% drug release was plotted against the corresponding time 
to obtain the curve as shown in Figure 5. 
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Figure 5: Comparison of Dissolution Profile of Generic and Branded generic Capsul 
Appearance [17] 
Capsules produced on a small or a large scale should be 
uniform in appearance. Visual or electronic inspection 
should be undertaken to detect any flaws in the integrity and 
appearance of the capsule. Evidence of physical instability is 
demonstrated by gross changes in appearance, including 
hardening or softening, cracking, swelling, mottling, printing 
mistake or discoloration of the shell. Defective capsules 
should be rejected. 
Size and Shape [17] 
Hard capsules are made in a range of sizes, the standard 
industrial ones in use today for human medicines range from 
size from 000 (the largest, 1.40 ml) to 5 (the smallest, 0.13 
ml) are commercially available. 
Unique Identification Markings [17] 
Capsule surfaces may bear symbols or other unique 
identification markings for better identification. 
Content of Active Ingredients [17] 
For this test a sample of the contents is assayed as described 
in individual monographs and calculates the amount of 
active ingredient in each capsule. According to IP the range 
for the content of active ingredient stated in the monograph 
is based on the requirement that 20 capsules. In the 
circumstances where 20 capsules cannot be obtained, a 
smaller number, which must not be less than 5, may be used, 
but to allow for sampling errors the tolerances are widened 
in accordance with the limits and proportionately smaller or 
larger allowances should be made. 
Uniformity of Mass [17] 
For this test weigh an intact capsule. Open the capsule 
without losing any part of the shell and remove the contents 
as completely as possible. Weigh the shell. The weight of the 
contents is the difference between the weighing. Repeat the 
procedure with a further 19 capsules. Determine the average 
mass. According to IP capsules not more than 2 of the 
individual masses deviate from the average mass by more 
than the percentage deviation as per the limits and none 
deviates by more than twice that percentage. 
Disintegration Test [17] 
The disintegration apparatus, described in I.P was used for 
the study. It contains 2 basket rack assembly. Each basket 
rack assembly consists of 6 glass tubes that are 3 inches 
long, open at the top and held against 10 mesh size at the 
bottom. Each Capsule was placed in each tube, and the 
basket rack was positioned in 1-L beaker of distilled water. 
The 37±2°C temperature was maintained throughout the 
study.
 
Table 7:  Identification test: [17] 
Sr No. Drug name Amoxicillin Trihydrate 
Branded generic - Wymox Generic - Aequimox 
1 Manufacturer Pfizer Ltd. Zydus Healthcare Ltd. 
2 Shape Cylindrical  Cylindrical  
3 Description Each hard gelatin capsule contains: Amoxicillin 
Trihydrate I.P. equivalent to Amoxicillin 250 mg 
Each hard gelatin capsule contains: Amoxicillin 
Trihydrate I.P. eq. to Amoxicillin 250 mg 
4 Color Pink and Black Red and White 
5 Dosage As prescribed by the physician As directed by the physician 
6 Storage Store protected from moisture at a temperature 
not exceeding 300 C. 
Store protected from light and moisture, at a 
temperature not exceeding 300 C. 
7 Mfg. Lic. no. SP- 46/76 48/UA/SC/P-2013 
8 Mfg. date 09/2017 04/2018 
9 Exp. date 08/2019 03/2020 
10 Price (PER 10 
CAPSULES) 
Rs.: 22.14 Rs.: 23.10 
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Table 8: Physiochemical evaluation: [17] 
Sr 
No. 
Drug name Amoxicillin Trihydrate 
 Wymox Aequimox 
1 Content of active ingredients 
(Limits: between 90 and 110 %) 
UV: 98.46-102.82 % 
HPLC: 99.89-102.27% 
UV: 98.23-102.97 % 
HPLC: 98.66-102.96% 
2 Uniformity of mass 
(not more than 2 of the individual masses 
deviate from the average mass by more than 
the percentage deviation) 
Test complies with I.P. 
 
Test complies with I.P. 
 
3 Disintegration time 
(Not more than 30 min) 
18 min 15 min 
4 Dissolution test 
(Not less than 70 per cent of the stated 
amount) % release Not less than 98.53 % % release Not less than 94.89 % 
 
CONCLUSION 
Based on such studies; their result and possible outcomes, 
opinion and doubt about the generic medicines need to be 
alter in order to help society and availability of medicines in 
reasonable prices. During the study it was observed that 
both variants of capsules were found to be in permissible 
range for all the quantitative and qualitative parameters as 
described in Indian Pharmacopoeia. And there was no any 
significant difference between both the branded generic and 
generic variant. 
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